Long-term safety study for diabetic foot ulcer treatment
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This study follows up on patients who received an experimental cell sheet (ALLO-ASC-DFU) or a placebo in a previous trial. It checks for any new safety concerns over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in the earlier ALLO-ASC-DFU-302 trial and received either the active treatment or placebo.
- You can give written permission to join the study.
- You agree to follow the study's rules and visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a special treatment (cellular acellular and matrix-like products) to standard wound care helps diabetic foot ulcers and venous leg ulcers heal faster. It may be an option if you have a diabetes-related foot ulcer that hasn't healed with standard care.
This trial tests whether injecting your own fat stem cells into a diabetic foot ulcer can help it heal. It is for people with a specific type of foot sore that hasn't healed after 6 weeks of standard care.
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
This trial tests a special membrane made from donated birth tissue (perinatal membrane) placed on a diabetic foot ulcer to help it heal faster. It's for people with diabetes whose foot ulcer hasn't healed after standard care for 4 weeks to a year.
This trial tests whether COMS One is safe and effective for healing a specific diabetic foot ulcer. It may help people whose ulcer is not healing well, especially when blood flow to the foot is limited.
This trial tests a new cell treatment for diabetic foot ulcers by injecting special regulatory monocytes (OPM cells) to help heal wounds. It is for patients with mild to moderate ulcers that haven't healed for over a month.
Hear when a new Diabetic Foot Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.